MRD Testing Is Becoming the Most Important Tool in Oncology Drug Development: Q&A with Eric Matthews
MRD testing is transforming oncology trials — compressing timelines, enriching populations, and generating earlier answers.
Eric Matthews
Advertisement
General manager of biopharma at Natera.
Articles by Eric Matthews
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Requests Updated Safety Label Warning Across All GLP-1 Receptor Agonist for Potential Risk of NAION
2
FDA Approves asundexian for Secondary Stroke Risk Reduction
3
Where AI Can Strengthen Clinical Research, and Where Patient Input is More Important
4
AstraZeneca Acquires Omniose, Adding Bioconjugation Platform to Vaccine Pipeline
5